Gazda Hanna T, Sheen Mee Rie, Vlachos Adrianna, Choesmel Valerie, O'Donohue Marie-Françoise, Schneider Hal, Darras Natasha, Hasman Catherine, Sieff Colin A, Newburger Peter E, Ball Sarah E, Niewiadomska Edyta, Matysiak Michal, Zaucha Jan M, Glader Bertil, Niemeyer Charlotte, Meerpohl Joerg J, Atsidaftos Eva, Lipton Jeffrey M, Gleizes Pierre-Emmanuel, Beggs Alan H
Division of Genetics and Program in Genomics, The Manton Center for Orphan Disease Research, Children's Hospital Boston, Boston, MA 02115, USA.
Am J Hum Genet. 2008 Dec;83(6):769-80. doi: 10.1016/j.ajhg.2008.11.004.
Diamond-Blackfan anemia (DBA), a congenital bone-marrow-failure syndrome, is characterized by red blood cell aplasia, macrocytic anemia, clinical heterogeneity, and increased risk of malignancy. Although anemia is the most prominent feature of DBA, the disease is also characterized by growth retardation and congenital anomalies that are present in approximately 30%-50% of patients. The disease has been associated with mutations in four ribosomal protein (RP) genes, RPS19, RPS24, RPS17, and RPL35A, in about 30% of patients. However, the genetic basis of the remaining 70% of cases is still unknown. Here, we report the second known mutation in RPS17 and probable pathogenic mutations in three more RP genes, RPL5, RPL11, and RPS7. In addition, we identified rare variants of unknown significance in three other genes, RPL36, RPS15, and RPS27A. Remarkably, careful review of the clinical data showed that mutations in RPL5 are associated with multiple physical abnormalities, including craniofacial, thumb, and heart anomalies, whereas isolated thumb malformations are predominantly present in patients carrying mutations in RPL11. We also demonstrate that mutations of RPL5, RPL11, or RPS7 in DBA cells is associated with diverse defects in the maturation of ribosomal RNAs in the large or the small ribosomal subunit production pathway, expanding the repertoire of ribosomal RNA processing defects associated with DBA.
钻石-黑范贫血(DBA)是一种先天性骨髓衰竭综合征,其特征为红细胞发育不全、大细胞性贫血、临床异质性以及恶性肿瘤风险增加。尽管贫血是DBA最突出的特征,但该疾病还具有生长发育迟缓以及先天性异常的特点,约30%-50%的患者存在这些情况。在大约30%的患者中,该疾病与四个核糖体蛋白(RP)基因RPS19、RPS24、RPS17和RPL35A的突变有关。然而,其余70%病例的遗传基础仍不清楚。在此,我们报告了RPS17中的第二个已知突变以及另外三个RP基因RPL5、RPL11和RPS7中的可能致病突变。此外,我们在其他三个基因RPL36、RPS15和RPS27A中鉴定出了意义不明的罕见变异。值得注意的是,对临床数据的仔细审查表明,RPL5中的突变与多种身体异常有关,包括颅面、拇指和心脏异常,而孤立的拇指畸形主要出现在携带RPL11突变的患者中。我们还证明,DBA细胞中RPL5、RPL11或RPS7的突变与核糖体大亚基或小亚基产生途径中核糖体RNA成熟的多种缺陷有关,从而扩大了与DBA相关的核糖体RNA加工缺陷的范围。